Management of Hypertensive Emergencies
Definition and Recognition
- The American Heart Association defines hypertensive emergency as severe blood pressure elevation (>180/120 mmHg) with evidence of new or worsening target organ damage, which may include hypertensive encephalopathy, intracerebral hemorrhage, acute myocardial infarction, or acute renal failure 1, 3
- The European Society of Cardiology notes that target organ damage in hypertensive emergencies can also include acute left ventricular failure with pulmonary edema, unstable angina, aortic dissection, or eclampsia 4, 1
- The 1-year mortality rate for untreated hypertensive emergencies exceeds 79%, with median survival of only 10.4 months, emphasizing the need for prompt recognition and treatment 1, 3
- Hypertensive emergencies must be distinguished from hypertensive urgencies, which involve severe blood pressure elevation without progressive target organ dysfunction, according to the European Heart Journal 4, 2
Initial Management Steps
- The American College of Cardiology recommends admitting patients with hypertensive emergencies to an intensive care unit for continuous blood pressure monitoring and parenteral administration of appropriate antihypertensive agents to prevent further target organ damage 1, 5
- The European Heart Journal suggests using parenteral antihypertensive agents for precise blood pressure control, selecting medication based on the specific type of organ damage present, and monitoring for excessive falls in pressure that may precipitate renal, cerebral, or coronary ischemia 4, 1
- The American Heart Association advises selecting appropriate medication based on specific type of organ damage present and monitoring for excessive falls in pressure 5, 6
Blood Pressure Reduction Targets
- For most hypertensive emergencies, the American Heart Association recommends reducing mean arterial blood pressure by no more than 25% within the first hour, and then further reducing blood pressure to 160/100-110 mmHg within the next 2-6 hours 4, 1
- After stability is confirmed, the European Heart Journal suggests gradually reducing blood pressure toward normal over the next 24-48 hours 1, 3
- In special situations such as aortic dissection, the American College of Cardiology recommends reducing systolic blood pressure to <120 mmHg within the first hour and maintaining heart rate <60 bpm 1, 5
- For ischemic stroke, limited evidence supports immediate blood pressure reduction, but the European Heart Journal generally recommends withholding blood pressure-lowering unless blood pressure >220/120 mmHg 7, 5
First-Line Parenteral Medications
- The American Heart Association recommends nicardipine as a first-line agent, with an initial dose of 5 mg/h IV, increasing every 5 min by 2.5 mg/h to maximum 15 mg/h, suitable for most hypertensive emergencies except acute heart failure 1, 7
- The European Heart Journal suggests labetalol as a first-line agent, with a dose of 20-80 mg IV bolus every 10 min or 0.4-1.0 mg/kg/h IV infusion, suitable for most hypertensive emergencies except acute heart failure 1, 5
- The American College of Cardiology recommends clevidipine as a first-line agent, with an initial dose of 1-2 mg/h IV, doubling every 90 seconds until blood pressure approaches target, maximum 32 mg/h, contraindicated in patients with soy/egg allergies or lipid metabolism disorders 1, 5
- The European Heart Journal suggests sodium nitroprusside as a first-line agent, with a dose of 0.25-10 μg/kg/min as IV infusion, but notes significant toxicity concerns and recommends avoiding its use when possible 4, 1
Common Pitfalls to Avoid
- The American Heart Association advises avoiding excessive blood pressure reduction, as too rapid or excessive lowering can cause cerebral, coronary, or renal hypoperfusion 4, 7
- The European Heart Journal recommends avoiding short-acting nifedipine due to the risk of uncontrolled blood pressure reduction 4, 7
- The American College of Cardiology suggests avoiding oral agents for initial management of hypertensive emergencies, as parenteral therapy provides more reliable and titratable control 1, 3